KENNEDY SPACE CENTER, Fla. (CASIS PR) – What if a single drop of blood were all that is needed to provide reliable medical diagnostics in any setting on—or even off—Earth? This week, NASA astronauts Douglas Hurley and Robert Behnken, who recently launched to the International Space Station (ISS) on the historic SpaceX Demo-2 mission, are working on an investigation from Boston-based biotech startup 1Drop Diagnostics to enhance a portable device that can run diagnostic tests from anywhere using just one drop of blood.
KENNEDY SPACE CENTER, Fla, (ISS National Lab PR) – At a time when so many feel isolated, the world came together with hopeful energy on Saturday to watch as two American astronauts were launched into orbit from U.S. soil for the first time in nearly a decade—and for the first time ever onboard a commercially owned spacecraft.
The successful SpaceX Demo-2 launch and docking, which carried NASA astronauts Doug Hurley and Robert Behnken from the Space Coast of Florida to the International Space Station (ISS), not only initiated a new era in American spaceflight but also rekindled the wonder and excitement of sending humans into space. Now, the two astronauts are getting to work in their new residence.
KENNEDY SPACE CENTER, Fla. March 6, 2020 (ISS National Lab PR) – What if the next breakthrough to improve patient care on Earth came from research off of Earth—in space? Three biotechnology startups have launched research to the International Space Station (ISS) U.S. National Laboratory, tackling a broad range of patient care objectives—from next-generation diagnostic tools to drug discovery and improved devices for drug delivery.